Artificial Intelligence in Remote Patient Monitoring Market

The Artificial Intelligence in Remote Patient Monitoring market was valued at USD 1,857.7 Million in 2024. The market is expected to reach USD 1,3261.1 Million by 2032, exhibiting a compound annual growth rate (CAGR) of 27.85% from 2025 to 2032.

Artificial Intelligence in Remote Patient Monitoring Market is based on artificial intelligence, machine learning, predictable analytics, natural language processing (NLP), and computer vision as it provides monitored patients, while they are not actively active in care of hospitals or other affiliated health facilities.

The Artificial Intelligence in Remote Patient Monitoring (AI in RPM) market is gradually transforming the way healthcare is delivered, especially for individuals with chronic diseases, surgical patients and individuals living in remote or undertaking areas. This market integrates AI algorithm to monitor significant signals with smart sensors, cloud technology and connected medical devices, assessing health risks and supporting real -time clinical communication.

The real advantage of AI lies in its ability to continuously process and analyze the huge amounts of patient data, triggering alert on time that helps prevent the visiting hospital and improve health results. It also works with digital health systems such as EMR, telehealth services and cloud platforms, making remote care not only more accessible, but also to suit more accurate and personal needs. While adoption initially began with large hospitals and clinics. The AI-managed monitoring tools are being used by domestic healthcare providers and outpatient centers to effectively manage patients with complex conditions.To know about the Research Methodology :- Request Free Sample Report

Global Artificial Intelligence in Remote Patient Monitoring Market Dynamics:

AI-Powered Handheld ECG to Transforms Cardiac Monitoring

The Movement towards more decentralized and smart cardiac diagnostics, AI-capable handheld ECG devices, are changing how heart condition is detected by offering quick, accurate, and remote assessment without relying on traditional, large-scale medical devices. These small, portable equipment use artificial intelligence to identify complex heart issues in real time, support rapid clinical decisions and make heart care more accessible. Their user-friendly design and dynamics make them ideal for areas with home use, primary clinics and limited health care resources, installing them as a game-changer in remote patient monitoring and heart health management.

• For instance, On June 25, 2024, Alivecor announced FDA clearance and commercial launch of its groundbreaking Kardia 12L ECG system and KAI 12L AI technology. The world’s first AI capable of detecting 35 cardiac assessments, including a heart attack, using a low lead set, powers this pocket-sized, handheld 12-lead ECG system. Trained on ECG over 1.75 million, KAI 12L employs an advanced neural network to give accurate results. Its single-cable design allows spontaneous integration in care settings, expanding access to important cardiac diagnostics with unprecedented comfort and mobility.

Empowering Hybrid Care Delivery Models to create opportunities for Artificial Intelligence in Remote Patient Monitoring Market

The use of hybrid care delivery models in healthcare represents a significant innovation in present-day health systems. This model brings together in-person activities and virtual service delivery to enhance both care and efficiency. This model employs AI technologies and allows for the supervision of patients that have transitioned out of the hospital while keeping a high quality of care. This decreases the burden on healthcare workers, maintains connection with patient support, and disseminates real time data to ensure quality decisions are made. Especially useful for chronic disease management and distant populations, hybrid care is re-prepared by making healthcare distribution more optimal, scalable, and patient-centered.

• For instance, On February 15, 2024, Virtua Health partnered with Care.ai. to implement its AI-powered Smart Care Facility Platform and ambient sensors, starting with Lady of Lourdes Hospital in New Jersey. The purpose of this collaboration is to enhance patient care, efficiency and support staff, connected care environment using advanced virtual care models and real-time ambient intelligence.

Regulatory Clarity Fueling AI RPM Innovation for Artificial Intelligence in Remote Patient Monitoring Market

Regulatory structures play an important role in the development of AI in remote patient monitoring by reducing ambiguity for innovators and care providers. When the oversight body provides a clear direction on the use of AI in health aspects such as body security, efficacy and ongoing monitoring, it enhances confidence, accelerates approval, and encourages comprehensive implementation. This auxiliary environment promotes innovation, attracts investment, and helps to integrate the AI-powered RPM tool more effectively in everyday clinical practice. As a result, these techniques are more likely to adopt these technologies on a scale in the healthcare system. Clear rules also support the long-term stability and accountability of AI solutions in patient care.

• For instance, On January 30, 2024, United States FDA's Center for Devices and Radiological Health (CDRH) released a public call for response to using AI/ML technologies to detect pre-diabetics and type 2 diabetes. This highlights the growing regulatory support for the AI-based remote monitoring tools.

Limited Access to High-Quality, Representative Health Data to create challenges for Artificial Intelligence in the Remote Patient Monitoring Market

AI systems in remote patient monitoring depend on a clean, well-labeled, and vast amount of diverse medical data to perform accurately. However, in many cases, the available health data is inconsistent, biased, or a decreased quality, especially in underserved communities and lower-income regions. It reduces the reliability of the AI model, possibly leading to wrong diagnoses and less accurate health predictions. Also, the lack of innovation standards for data collection and poor systems make it complicated to fully train and validate these models, which in turn delays the regulatory withdrawal and clinical uptake.

• For instance, On January 8, 2025, A study reveals that while 65% of U.S. hospitals use AI-assisted predictive tools, fewer than half assess them for bias. This difference increases concerns over the accuracy and fairness of the AI model, especially hospitals have adopted them rapidly in important health care operations.

Global Artificial Intelligence in Remote Patient Monitoring Market Segment Analysis:

Based on component, Artificial Intelligence in Remote Patient Monitoring Market is segmented into AI-enabled Devices, Software & Platform, Services. AI-enabled Devices segment dominates the market in 2024 and is expected to capture the largest market share during the forecast period. This dominance is inspired by the growing adoption of advanced wearables and biosensors that allow continuous, non-invasive, real-time patient monitoring. Such devices help in initial diagnosis and help reduce hospital visits by continuously tracking the main health matrix and significant signals. Integration of AI increases clinical efficiency and accuracy, making them valuable equipment for distance care. Awareness about preventive healthcare and increasing preference for home-based monitoring solutions also contribute to this trend.

In addition, ongoing technological progress and favorable regulator supports are strengthening the development and market leadership of this segment worldwide.

Based on clinical application, Artificial Intelligence in Remote Patient Monitoring Market is segmented into Cardiovascular Monitoring, Diabetes Management, Respiratory Monitoring, Oncology Remote Monitoring, Mental Health & Behavioral Monitoring, Post-operative & Home Recovery, Elderly/Frail Patient Monitoring, Sleep Disorders & Neurological Monitoring, Others. Diabetes Management segment dominates the market in 2024 and is expected to capture the largest market share during the forecast period.

Diabetes is one of the most prevalent chronic diseases, requiring continuous observation and early management to avoid serious health issues. AI-powered remote patient surveillance tools supported for diabetes support the real-time tracking of blood sugar levels, give early warnings to irregular patterns, and provide analog guidance to both users and healthcare professionals.

Global Artificial Intelligence in Remote Patient Monitoring Market Regional Insights:

North America was a dominant region in 2024 and is expected to hold the largest market share in the Artificial Intelligence in Remote Patient Monitoring Market over the forecast period Due to rapid adoption of advanced technologies within the healthcare sector. Region's Health Service infrastructure is highly receptive to AI integration for real -time patient monitoring, and consumers are embracing rapidly associated connected health solutions. In addition, increasing elderly population, strong awareness about chronic illness management, and an increase in the government initiative and fuel market for digital healthcare. The presence of major medical technology and AI-centric companies in North America also strengthens its leadership position. The presence of major medical technology and AI-centric companies in North America also strengthens its leadership position.

Competitive Landscape

Koninklijke Philips N.V. is a global leader in digital health, offering AI-powered remote monitoring via its HealthSuite platform. The company operates internationally and offers smart, connected health solutions through its HealthSuite digital platform. By combining medical devices with advanced analytics, Philips provides scalable RPM technologies that support continuous monitoring, chronic disease management, and increase clinical decisions in various healthcare environment.

Alivecor, Inc., is a leading player in AI-powered cardiac care which focuses on portable ECG technologies. The company has had a remarkable effect in the remote patient monitoring (RPM) space, particularly for heart health, by combining artificial intelligence with compact and easy-to-use devices. 22 With innovations such as FDA-approved KardiaMobile and Kardia 12L. AliveCor is helping shift cardiac diagnostics from hospitals to more accessible, everyday settings.

Recent Development

• In April 2025, Mediana Company, Ltd launched an AI medical business, which expanded from hardware manufacturing to AI-based medical solutions. Leveraging Selvas AI’s software, Mediana aims to increase the patient's monitoring, diagnosis, and telemedicine services using real-time hospital data and connected medical equipment.

• In June 2025, Mayo Clinic introduced an AI-managed virtual care program in partnership with digital health firms. This initiative improves remote patient monitoring and care coordination through machine learning, reflecting a widespread tendency of hospitals embracing AI for documentation, engagement, and well-organized administrative procedures.

Artificial Intelligence in Remote Patient Monitoring Market Scope: Inquire before buying

Artificial Intelligence in Remote Patient Monitoring Market by Region

North America (United States, Canada and Mexico)
Europe (United Kingdom, France, Germany, Italy, Spain, Sweden, Russia, Rest of Europe)
Asia Pacific (China, Japan, South Korea, India, Australia, Malaysia, Thailand, Vietnam, Indonesia, Philippines, Rest of APAC)
Middle East and Africa (South Africa, GCC, Nigeria, Egypt, Turkey, Rest of MEA)
South America (Brazil, Argentina, Colombia, Chile, Peru, Rest of South America)

Artificial Intelligence in Remote Patient Monitoring Key Players are:

North America
1. GE HealthCare (US)
2. Boston Scientific Corporation (US)
3. ResMed (US)
4. AliveCor, Inc. (US)
5. Beijing Choice Electronic Tech Co. Ltd (US)
6. TytoCare Ltd. (US)
7. Glooko, Inc. (US)
8. Welldoc, Inc. (US)
9. Zeto Inc. (US)
10. Masimo (US)
11. iRhythm Inc. (US)
12. BioIntelliSense (US)
13. Jorie Healthcare Partners (US)
14. HealthSnap, Inc. (US)
15. Dexcom (US)
16. Abbott (US)
17. 100Plus (US)
18. Datos (US)
19. Credo Health AI(US)

Europe

20. Koninklijke Philips N.V.(Netherlands)
21. Medtronic (Ireland)
22. F. Hoffmann-La Roche Ltd (Roche Diagnostics) (Switzerland)
23. Biotronik (Germany)
24. Idoven (Spain)

Asia Pacific

25. OMRON Healthcare, Inc. (Japan)
26. NIHON KOHDEN CORPORATION (Japan)
27. Turtle Shell Technologies Pvt Ltd (Dozee) (India)
28. MEDIANA Co., Ltd. (korea)

Middle East and Africa
29. Biobeat (Israel)
30. Others

FAQ:

1. How big is the Global Artificial Intelligence in Remote Patient Monitoring Market?
Ans. The Artificial Intelligence in Remote Patient Monitoring Market size was valued at USD 1,857.7 Mn in 2024, and the Artificial Intelligence in Remote Patient Monitoring Market revenue is expected to grow at a CAGR of 27.85 % from 2025 to 2032, reaching nearly USD 1,3261.1 Mn

2. What are the key drivers of the Global Artificial Intelligence in Remote Patient Monitoring Market growth?
Ans. Rising prevalence of chronic and lifestyle-related diseases, Expansion of telehealth and remote care demand.

3. Which is the dominating region in the Global Artificial Intelligence in Remote Patient Monitoring Market?
Ans. North America is the dominating region in the Artificial Intelligence in Remote Patient Monitoring Market.

4. Who are the key players in the Global Artificial Intelligence in Remote Patient Monitoring Market?
Ans. GE HealthCare (US), Boston Scientific Corporation (US), ResMed (US), AliveCor, Inc. (US), Beijing Choice Electronic Tech Co. Ltd (US), TytoCare Ltd. (US).